Milton Keynes charity gives £2.8m funding for brain tumour research
A Milton Keynes charity has granted £2.8m of funding for scientists working on treatments for low-grade brain tumours.
Brain Tumour Research charity is providing the 5-year donation to teams studying low-grade brain tumours - slow-growing tumours that are unlikely to spread to other parts of the brain, but can still have huge health impacts.
The funding will allow scientists to learn more about how these tumours develop, to help them create life-changing therapies.
The investment builds on a partnership between Brain Tumour Research and the University of Plymouth which first began in 2014.


The Brain Tumour Research Centre of Excellence at the University of Plymouth is a hub for world-leading research into low-grade tumours including low-grade glioma, meningioma, and schwannoma.
Actor and producer Craig Russell underwent surgery for a low-grade meningioma at Derriford Hospital in Plymouth in March 2023. Now an Ambassador for Brain Tumour Research, he said: “Low-grade tumours aren’t low impact. With limited treatment options, these tumours have lifelong consequences for patients and their families.
"I am incredibly pleased that Brain Tumour Research is continuing the partnership with the University of Plymouth, focused on delivering tangible progress for patients. Together we will find a cure.”
The new funding will allow researchers to explore different pathways to improving treatment for patients. These include understanding the role of the immune system in tumour growth, finding new drugs to make radiotherapy more effective, and testing existing drugs for other medical conditions to see if they can also benefit brain tumour patients.
The team has had previous success with this approach, with a trial underway testing HIV drugs in patients with schwannoma.
More than 100,000 people in the UK are estimated to be living with a brain tumour or the long-term impact of their diagnosis, yet research into the disease has been chronically underfunded.
Shannon Moore, 29, from Winslow in Buckinghamshire, was diagnosed with a rare craniopharyngioma brain tumour when she was nine.
She went through emergency surgery and has endured several operations over the years, plus treatment including radiotherapy and hormone replacement.
She said: “I’m really pleased the Centre in Plymouth is getting this funding. Research into low-grade brain tumours is so important because they cause lots of different side effects, causing people to struggle with everyday life. I’m certified blind, I suffer from chronic fatigue and I have an inactive thyroid, so I have to take a lot of medication.
“I know people who have been through the same as me, but their side effects are different to mine and have impacted their lives much more. They suffer from seizures and have 24-hour care. It’s not fair to see anyone else go through that.
“Research is so important because it will give us a better understanding of the disease so we can stop it from affecting more people.”
Leading this new phase of work is David Parkinson, Professor of Neuroscience at the University of Plymouth and the newly appointed Director of the Brain Tumour Research Centre of Excellence.
Professor Parkinson said: “This investment from Brain Tumour Research will allow us to build on the world-class foundation established here over the last 10 years and accelerate progress towards much-needed treatments for low-grade brain tumours.
"By working across disciplines and focusing on translating discoveries from the lab to the clinic, we aim to make a real difference to patients and their families.”
After the first three years of the five-year investment, the Centre will undergo an expert review designed to track progress and strengthen its impact moving forward.
Underpinning the Centre will be the continued growth of the Plymouth Biobank - providing researchers a vital resource of patient-linked tumour samples, blood samples, health information, and genetic data for world-class research.
Dan Knowles, CEO at Brain Tumour Research, said: “This £2.8 million funding from Brain Tumour Research secures the future of our Centre of Excellence at Plymouth, allowing our scientists to continue their world-leading work into the causes, prevention, and treatment of brain tumours.”
Brain Tumour Research funds sustainable research at dedicated centres around the UK. It also campaigns for the Government and larger cancer charities to invest more in brain tumour research, to advance new treatments and ultimately find a cure.
The charity is the driving force behind the call for a national annual spend of £35 million in order to improve survival rates and patient outcomes in line with other cancers such as breast cancer and leukaemia.
You can find more information and donate at the Brain Tumour Research website.